K R Hess Selected Research

K R Hess Research Topics

13	Neoplasms (Cancer) 01/2021 - 10/2000
4	Glioblastoma (Glioblastoma Multiforme) 08/2009 - 10/2000
3	Breast Neoplasms (Breast Cancer) 01/2017 - 05/2007
3	Pancreatic Neoplasms (Pancreatic Cancer) 08/2001 - 11/2000
2	Pathologic Complete Response 01/2017 - 05/2007
2	Glioma (Gliomas) 05/2002 - 10/2000
1	Cancer Pain 04/2017
1	Neutropenia 01/2017
1	Exanthema (Rash) 10/2008
1	Fatigue 10/2008
1	Leukopenia 10/2008
1	Thrombocytopenia (Thrombopenia) 10/2008
1	Wound Infection (Wound Infections) 07/2001
1	Abscess 07/2001
1	Anastomotic Leak 07/2001
1	Surgical Wound Infection 07/2001
1	Disease Progression 03/2001
1	Adenocarcinoma 03/2001
1	Wounds and Injuries (Trauma) 10/2000
1	Sarcoma (Soft Tissue Sarcoma) 10/2000

3	Estrogen ReceptorsIBA 09/2012 - 12/2005
2	Everolimus FDA Link 01/2021 - 09/2008
2	Temozolomide (Temodar)FDA LinkGeneric 08/2009 - 09/2008
2	Carboplatin (JM8)FDA LinkGeneric 10/2008 - 05/2002
2	Fluorouracil (Carac)FDA LinkGeneric 05/2007 - 11/2000
2	Vincristine (Oncovin)FDA LinkGeneric 05/2002 - 10/2000
2	Procarbazine (Matulane)FDA Link 05/2002 - 10/2000
1	vandetanib (ZD6474)IBA 01/2021
1	talazoparibIBA 01/2017
1	Hormones (Hormone)IBA 01/2017
1	InterferonsIBA 08/2009
1	Interferon-alpha2bIBA 08/2009
1	TensinsIBA 10/2008
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2008
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2008
1	ErbB Receptors (EGF Receptor)IBA 10/2008
1	Telomerase (Telomerase Reverse Transcriptase)IBA 09/2008
1	Sirolimus (Rapamycin)FDA Link 09/2008
1	taxaneIBA 05/2007
1	Taxoids (Taxanes)IBA 05/2007
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2007
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2007
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2007
1	GABA-A Receptors (GABA(A) Receptor)IBA 12/2005
1	OligonucleotidesIBA 12/2005
1	gamma-Aminobutyric Acid (GABA)IBA 12/2005
1	Biomarkers (Surrogate Marker)IBA 12/2005
1	Lomustine (CCNU)FDA Link 05/2002
1	Matrix Metalloproteinases (MMPs)IBA 08/2001
1	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 10/2000
1	Alkylating AgentsIBA 10/2000
1	Eflornithine (Ornidyl)FDA Link 10/2000

5	Therapeutics 01/2021 - 10/2000
4	Drug Therapy (Chemotherapy) 04/2013 - 10/2000
4	Radiotherapy 05/2002 - 10/2000
3	Neoadjuvant Therapy 01/2017 - 10/2000
2	Drug Tapering 01/2017 - 10/2008
2	Pancreaticoduodenectomy 07/2001 - 03/2001
1	Cordotomy 04/2017
1	Aftercare (After-Treatment) 05/2002
1	Decompression 07/2001
1	Stents 07/2001
1	Laparotomy 06/2001
1	Chemoradiotherapy 03/2001
1	Combined Modality Therapy 03/2001
1	Adjuvant Radiotherapy 11/2000
1	Combination Drug Therapy (Combination Chemotherapy) 10/2000
1	PCV regimen 10/2000